1068 Non-Invasive Focused Ultrasound Modulates GI Inflammation and Reduces Alpha-Synuclein Deposition in Prodromal Model of Parkinson's Disease

View at publisher Summarise with VIRAT
Authors: John Y. Chen, Kainat Akhtar, Dev Dwivedi, Peter McCarthy, Yifan Kao, Veda Vyakaranam, Kydada Mills, Amal Siddiqui, Diya Rajput, Nicole Forman, Elizabeth Dybas, Eliyahu M. Kochman
+1 more Damian Seung-Ho Shin
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: Parkinson’s disease (PD) is marked by a prodrome of non-motor symptoms, with up to 80% of patients experiencing gastrointestinal (GI) dysfunction 20 years prior to diagnosis. This aligns with the Braak hypothesis, which posits 90% of sporadic PD is attributed to the misfolding/phosphorylation of alpha-synuclein (pα-syn) protein in the GI tract prior to propagating to the brain via the vagus nerve. METHODS: We recapitulated a rat model of gut-first PD through injection of α-syn pre-formed fibrils (PFFs), which seeds wildtype α-syn to pα-syn, into the mucosal layer of the GI tract. GI cytokine expression and pα-syn levels were compared against saline injected controls at 3, 7, 14, and 21 days post injection (DPI). These outcomes were compared against α-syn PFF and saline injected animals at 21 DPI who received FUS treatment on the celiac plexus from 7 to 21 DPI. RESULTS: α-syn PFF injection increased expression of CCL-5 compared to saline controls (p = 0.0378, n = 7, 6). FUS treatment decreased CCL-5, CXCL-1, IL-13, IFN-γ, IL-1α, and IL-10 while increasing IL-4 expression in α-syn PFF injected animals (p < 0.05, n = 7, 6). FUS decreased pα-syn deposition in the GI tract of α-syn PFF injected animals commensurate to saline controls (p = 0.029, n = 7, 6) despite no alteration in general cell density. CONCLUSIONS: FUS treatment decreased pα-syn deposition and modulated cytokine expression following α-syn PFF injection in a rat model of prodromal PD. Future study will evaluate FUS as a novel, non-invasive therapeutic in modulating intracranial α-syn PFF deposition and PD disease progression.

Fields of Study & Subjects

Parkinson's Disease Mechanisms and Treatments Ultrasound and Hyperthermia Applications Neuroinflammation and Neurodegeneration Mechanisms

Publication details

Journal / source
Neurosurgery
Volume
72
Issue
Supplement_1
Pages
195–195
Publication date
26 March 2026
Language
EN